Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 67 articles:
HTML format
Text format



Single Articles


    December 2016
  1. NIES M, Klein Hesselink MS, Huizinga GA, Sulkers E, et al
    Long-term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Dec 21:jc20162246. doi: 10.1210/jc.2016-2246.
    PubMed     Text format     Abstract available


    October 2016
  2. MOON JH, Kim KM, Oh TJ, Choi SH, et al
    The effect of TSH-suppression on vertebral trabecular bone scores in patients with differentiated thyroid carcinoma.
    J Clin Endocrinol Metab. 2016 Oct 18:jc20162740.
    PubMed     Text format     Abstract available


  3. TALLINI G, Tuttle RM, Ghossein RA
    THE HISTORY OF THE FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20162976.
    PubMed     Text format     Abstract available


    September 2016
  4. KAKARMATH S, Heller HT, Alexander CA, Cibas ES, et al
    Clinical, Sonographic, and Pathologic Characteristics of RAS-positive versus BRAF-positive Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Sep 30:jc20162620.
    PubMed     Text format     Abstract available


  5. XU JY, Murphy WA Jr, Milton DR, Jimenez C, et al
    Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Sep 23:jc20162815.
    PubMed     Text format     Abstract available


  6. CHEREAU N, Giudicelli X, Pattou F, Lifante JC, et al
    Diffuse sclerosing variant of papillary thyroid carcinoma is associated with aggressive histopathological features and a poor outcome: Results of a large multicentric study.
    J Clin Endocrinol Metab. 2016 Sep 14:jc20162341.
    PubMed     Text format     Abstract available


    August 2016
  7. TORREGROSSA L, Viola D, Sensi E, Giordano M, et al
    Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.
    J Clin Endocrinol Metab. 2016 Aug 29:jc20161775.
    PubMed     Text format     Abstract available


  8. CHOU CK, Chi SY, Huang CH, Chou FF, et al
    IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2016 Aug 17:jc20162276.
    PubMed     Text format     Abstract available


    March 2016
  9. KLEIN HESSELINK MS, Nies M, Bocca G, Brouwers AH, et al
    Pediatric differentiated thyroid carcinoma in the Netherlands: a nationwide follow-up study.
    J Clin Endocrinol Metab. 2016 Mar 10:jc20153290.
    PubMed     Text format     Abstract available


  10. KURIEN BT, Lane JT, Scofield RH
    Letter to the Editor: Getting to the True Values of Thyroglobulin and Anti-Thyroglobulin Antibodies.
    J Clin Endocrinol Metab. 2016;101:L38-9.
    PubMed     Text format    


  11. LATTEYER S, Klein-Hitpass L, Khandanpour C, Zwanziger D, et al
    A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
    J Clin Endocrinol Metab. 2016;101:1016-22.
    PubMed     Text format     Abstract available


  12. LADENSON PW
    Precision Medicine Comes to Thyroidology.
    J Clin Endocrinol Metab. 2016;101:799-803.
    PubMed     Text format     Abstract available


    February 2016
  13. YU Y, Zhang J, Lu G, Li T, et al
    Clinical relationship between IgG4-positive Hashimoto's thyroiditis and papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2016 Feb 11:jc20153783.
    PubMed     Text format     Abstract available


  14. FINKEL A, Liba L, Simon E, Bick T, et al
    Sub-clonality for BRAF mutation in papillary thyroid carcinoma is associated with earlier disease stage.
    J Clin Endocrinol Metab. 2016 Feb 2:jc20154031.
    PubMed     Text format     Abstract available


  15. ALVES TG, Kasamatsu TS, Yang JH, Meneghetti MC, et al
    Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay.
    J Clin Endocrinol Metab. 2016;101:653-8.
    PubMed     Text format     Abstract available


    January 2016
  16. YANG X, Liang J, Li T, Zhao T, et al
    Preablative stimulated thyroglobulin correlates to new therapy response system in differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2016 Jan 20:jc20154016.
    PubMed     Text format     Abstract available


  17. LUO J, Phillips L, Liu S, Wactawski-Wende J, et al
    Diabetes, diabetes treatment and risk of thyroid cancer.
    J Clin Endocrinol Metab. 2016 Jan 13:jc20153901.
    PubMed     Text format     Abstract available


  18. CHENG W, Liu R, Zhu G, Wang H, et al
    Robust Thyroid Gene Expression and Radioiodine Uptake Induced by Simultaneous Suppression of BRAF V600E and Histone Deacetylase in Thyroid Cancer Cells.
    J Clin Endocrinol Metab. 2016 Jan 11:jc20153433.
    PubMed     Text format     Abstract available


  19. NISHIMOTO K, Seki T, Kurihara I, Yokota K, et al
    Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    J Clin Endocrinol Metab. 2016;101:6-9.
    PubMed     Text format     Abstract available


    November 2015
  20. RUTTER MM, Jha P, Schultz KA, Sheil A, et al
    DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
    J Clin Endocrinol Metab. 2015 Nov 10:jc20152169.
    PubMed     Text format     Abstract available


  21. SHI X, Liu R, Basolo F, Giannini R, et al
    Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    J Clin Endocrinol Metab. 2015 Nov 3:jc20152917.
    PubMed     Text format     Abstract available


    October 2015
  22. KLEIN HESSELINK EN, Lefrandt JD, Schuurmans EP, Burgerhof JG, et al
    Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2015 Oct 19:jc20152782.
    PubMed     Text format     Abstract available


  23. KWONG N, Medici M, Angell TE, Liu X, et al
    The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk.
    J Clin Endocrinol Metab. 2015 Oct 14:jc20153100.
    PubMed     Text format     Abstract available


    September 2015
  24. BIBLE KC, Cote GJ, Demeure MJ, Elisei R, et al
    Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group.
    J Clin Endocrinol Metab. 2015 Sep 29:jc20152818.
    PubMed     Text format     Abstract available


  25. ANGELL TE, Frates MC, Medici M, Liu X, et al
    Afirma Benign Thyroid Nodules Show Similar Growth to Cytologically Benign Nodules During Follow Up.
    J Clin Endocrinol Metab. 2015 Sep 9:jc20152658.
    PubMed     Text format     Abstract available


  26. DE VATHAIRE F, Haddy N, Allodji R, Hawkins M, et al
    Thyroid radiation dose and other risk factors of thyroid carcinoma following childhood cancer.
    J Clin Endocrinol Metab. 2015 Sep 1:jc20151690.
    PubMed     Text format     Abstract available


  27. AHN HY, Min HS, Yeo Y, Ma SH, et al
    Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer.
    J Clin Endocrinol Metab. 2015;100:3486-93.
    PubMed     Text format     Abstract available


    August 2015
  28. JENDRZEJEWSKI J, Thomas A, Liyanarachchi S, Eiterman A, et al
    PTCSC3 is involved in papillary thyroid carcinoma development by modulating S100A4 gene expression.
    J Clin Endocrinol Metab. 2015 Aug 14:jc20152247.
    PubMed     Text format     Abstract available


  29. PACELLA CM, Mauri G, Achille G, Barbaro D, et al
    Outcomes and Risk Factors for Complications of Laser Ablation for Thyroid Nodules. A Multicenter Study on 1531 Patients.
    J Clin Endocrinol Metab. 2015 Aug 14:jc20151964.
    PubMed     Text format     Abstract available


  30. PRINSEN HT, Klein Hesselink EN, Brouwers AH, Plukker JT, et al
    Bone marrow function after I therapy in patients with differentiated thyroid carcinoma.
    J Clin Endocrinol Metab. 2015 Aug 11:jc20152124.
    PubMed     Text format     Abstract available


  31. NETZEL BC, Grebe SK, Carranza Leon BG, Castro MR, et al
    Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.
    J Clin Endocrinol Metab. 2015;100:E1074-83.
    PubMed     Text format     Abstract available


    July 2015
  32. BELOUSOV PV, Bogolyubova AV, Kim YS, Abrosimov AY, et al
    Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1zeta Autoantibody As a Potential Biomarker in Thyroid Neoplasia.
    J Clin Endocrinol Metab. 2015 Jul 21:jc20144260.
    PubMed     Text format     Abstract available


  33. CARHILL AA, Litofsky DR, Ross DS, Jonklaas J, et al
    Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.
    J Clin Endocrinol Metab. 2015 Jul 14:JC20151346.
    PubMed     Text format     Abstract available


  34. GIANI F, Vella V, Nicolosi ML, Fierabracci A, et al
    THYROSPHERES FROM NORMAL OR MALIGNANT THYROID TISSUE HAVE DIFFERENT BIOLOGIC, FUNCTIONAL AND GENETIC FEATURES.
    J Clin Endocrinol Metab. 2015 Jul 7:JC20144163.
    PubMed     Text format     Abstract available


  35. MACHENS A, Dralle H
    Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A.
    J Clin Endocrinol Metab. 2015;100:2539-45.
    PubMed     Text format     Abstract available


    June 2015
  36. JEON MJ, Kim WG, Mi Choi Y, Kwon H, et al
    Recent changes in the clinical outcome of papillary thyroid carcinoma with cervical lymph node metastasis.
    J Clin Endocrinol Metab. 2015 Jun 29:JC20152084.
    PubMed     Text format     Abstract available


  37. RUEL E, Thomas S, Roman S, Sosa JA, et al
    Response to the Letter by Katiman E., et al.
    J Clin Endocrinol Metab. 2015;100:L43-4.
    PubMed     Text format    


  38. ELLIYYIN K, Peng OC, Azmi KN
    Letter to the Editor.
    J Clin Endocrinol Metab. 2015;100:L41-2.
    PubMed     Text format    


    May 2015
  39. HUSSAIN AR, Bu R, Ahmed M, Jehan Z, et al
    Role of X-Linked Inhibitor of Apoptosis as a prognostic marker and therapeutic target in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2015 May 14:jc20144356.
    PubMed     Text format     Abstract available


  40. LABOURIER E, Shifrin A, Busseniers AE, Lupo MA, et al
    Molecular testing for miRNA, mRNA and DNA on fine needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2015 May 12:jc20151158.
    PubMed     Text format     Abstract available


    March 2015
  41. RUAN M, Liu M, Dong Q, Chen L, et al
    Iodide- and Glucose-handling Gene Expression Regulated by Sorafenib or Cabozantinib in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2015 Mar 13:jc20143023.
    PubMed     Text format     Abstract available


  42. AVRAM AM, Esfandiari NH, Kit Wong K
    Preablation 131-I scans with SPECT/CT contribute to thyroid cancer risk stratification and131-I therapy planning.
    J Clin Endocrinol Metab. 2015 Mar 3:jc20144043.
    PubMed     Text format     Abstract available


  43. SHIFRIN A, LiVolsi V, Shifrin-Douglas S, Zheng M, et al
    Primary and metastatic parathyroid malignancies: a rare or underdiagnosed condition?
    J Clin Endocrinol Metab. 2015;100:E478-81.
    PubMed     Text format     Abstract available


    February 2015
  44. PLEWS RL, Mohd Yusof A, Wang C, Saji M, et al
    A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth.
    J Clin Endocrinol Metab. 2015 Feb 24:jc20141777.
    PubMed     Text format     Abstract available


  45. JU HA E, Hwan Baek J, Won Kim K, Pyo J, et al
    Comparative Efficacy of Radiofrequency and Laser Ablation for the Treatment of Benign Thyroid Nodules: Systematic Review Including Traditional Pooling and Bayesian Network Meta-analysis.
    J Clin Endocrinol Metab. 2015 Feb 19:jc20144077.
    PubMed     Text format     Abstract available


  46. LAMARTINA L, Durante C, Filetti S, Cooper DS, et al
    Low and intermediate Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A systematic review of the literature.
    J Clin Endocrinol Metab. 2015 Feb 13:jc20143882.
    PubMed     Text format     Abstract available


  47. RUEL E, Thomas S, Dinan M, Perkins JM, et al
    Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate risk papillary thyroid cancer.
    J Clin Endocrinol Metab. 2015 Feb 2:jc20144332.
    PubMed     Text format     Abstract available


    January 2015
  48. PEILING YANG S, Bach AM, Michael Tuttle R, Fish SA, et al
    Frequent screening with serial neck ultrasound is more likely to identify false positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow
    J Clin Endocrinol Metab. 2015 Jan 29:jc20143651.
    PubMed     Text format     Abstract available


  49. LEE YA, Jung HW, Kim HY, Choi H, et al
    Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
    J Clin Endocrinol Metab. 2015 Jan 29:jc20143647.
    PubMed     Text format     Abstract available


  50. FAN D, Liu SY, van Hasselt CA, Vlantis AC, et al
    Estrogen receptor alpha induces pro-survival autophagy in papillary thyroid cancer via stimulating reactive oxygen species and extracellular-signal-regulated kinases.
    J Clin Endocrinol Metab. 2015 Jan 16:jc20143257.
    PubMed     Text format     Abstract available


  51. ROTONDI M, Coperchini F, Pignatti P, Magri F, et al
    Metformin Reverts the Secretion of CXCL8 Induced by TNF-alpha in Primary Cultures of Human Thyroid Cells: An Additional Indirect Anti-Tumor Effect of the Drug.
    J Clin Endocrinol Metab. 2015 Jan 15:jc20143045.
    PubMed     Text format     Abstract available


  52. SHI X, Liu R, Qu S, Zhu G, et al
    Association of TERT Promoter Mutation 1,295,228 C>T with BRAF V600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer.
    J Clin Endocrinol Metab. 2015 Jan 13:jc20143606.
    PubMed     Text format     Abstract available


  53. SUNDARESH V, Levine SN
    From hypocalcemia to hypercalcemia-an unusual clinical presentation of a patient with permanent postsurgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2015;100:21-4.
    PubMed     Text format     Abstract available


    November 2014
  54. BRESNER L, Banach R, Rodin G, Thabane L, et al
    Cancer-related Worry in Canadian Thyroid Cancer Survivors.
    J Clin Endocrinol Metab. 2014 Nov 13:jc20143169.
    PubMed     Text format     Abstract available


  55. WANG K, Yang Y, Wu Y, Chen J, et al
    The association between insulin resistance and vascularization of thyroid nodules.
    J Clin Endocrinol Metab. 2014 Nov 4:jc20142723.
    PubMed     Text format     Abstract available


    October 2014
  56. DADU R, Shah K, Busaidy NL, Waguespack SG, et al
    Efficacy and Tolerability of Vemurafenib in Patients with BRAF -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience.
    J Clin Endocrinol Metab. 2014 Oct 29:jc20142246.
    PubMed     Text format     Abstract available


  57. SMITH N, Nucera C
    Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
    J Clin Endocrinol Metab. 2014 Oct 27:jc20142803.
    PubMed     Text format     Abstract available


  58. ADAM MA, Pura J, Goffredo P, Dinan MA, et al
    Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.
    J Clin Endocrinol Metab. 2014 Oct 22:jc20143039.
    PubMed     Text format     Abstract available


  59. LUPOLI G, Okosieme O, Evans C, Clark P, et al
    Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2014 Oct 16:jc20142725.
    PubMed     Text format     Abstract available


  60. FREESMEYER M, Winkens T, Darr A
    Diagnosis of Small Papillary Thyroid Cancer via Sensor-navigated Iodine PET/Ultrasound (I-PET/US) Fusion.
    J Clin Endocrinol Metab. 2014 Oct 14:jc20143003.
    PubMed     Text format     Abstract available


  61. SHIFRIN A, Zheng M, Jurewicz S, Vernick J, et al
    Patient with Tracheal Duplication Cyst Clinically Misdiagnosed as a Thyroid Nodule.
    J Clin Endocrinol Metab. 2014 Oct 14:jc20142106.
    PubMed     Text format     Abstract available


  62. BARDET S, Ciappuccini R, Quak E, Rame JP, et al
    Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer.
    J Clin Endocrinol Metab. 2014 Oct 10:jc20141199.
    PubMed     Text format     Abstract available


    September 2014
  63. CHINDRIS AM, Casler JD, Bernet VJ, Rivera M, et al
    Clinical and Molecular Features of Hurthle Cell Carcinoma of the Thyroid.
    J Clin Endocrinol Metab. 2014 Sep 26:jc20141634.
    PubMed     Text format     Abstract available


  64. COLAMAIO M, Puca F, Ragozzino E, Gemei M, et al
    miR-142-3p downregulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
    J Clin Endocrinol Metab. 2014 Sep 19:jc20142280.
    PubMed     Text format     Abstract available


  65. CABANILLAS ME, Hu MI, Jimenez C
    Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat-And with Which Drug-Those Are the Questions.
    J Clin Endocrinol Metab. 2014 Sep 19:jc20142811.
    PubMed     Text format     Abstract available


  66. KREJBJERG A, Bjergved L, Pedersen IB, Knudsen N, et al
    Thyroid nodules in an eleven-year DanThyr follow-up study.
    J Clin Endocrinol Metab. 2014 Sep 18:jc20142438.
    PubMed     Text format     Abstract available


  67. SPENCER C, Petrovic I, Fatemi S, LoPresti J, et al
    Serum Thyroglobulin (Tg) Monitoring of Patients with Differentiated Thyroid Cancer (DTC) using Sensitive (Second-Generation) Immunometric Assays (TgIMA) can be Disrupted by False-Negative and False-Positive Serum Thyroglobulin Autoantibody (TgAb) Misc
    J Clin Endocrinol Metab. 2014 Sep 16:jc20141203.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: